The study sets out to evaluate the target conformity of proton mini beams in comparison with X-ray stereotactic body radiation therapy and stereotactic radiosurgery.
Proton mini beam radiation therapy is an approach that allies the inherent physical advantages of protons with the normal tissue preservation when the tumour is irradiated below the current standard size of proton beams.
Stereotactic radiosurgery is a non-surgical radiation therapy used to treat functional abnormalities and small tumours of the brain. It can deliver precisely-targeted radiation in fewer high-dose treatments than traditional therapy.
Advanced Oncotherapy’s LIGHT system has been designed to generate a much smaller beam (minibeam) than is possible with current proton therapy technology. This increases the efficacy of treatment and improves the quality of life for patients through a reduction of side effects.
Last month, Advanced Oncotherapy raised £2.7m in a new share issue aimed at obtaining regulatory approval for its first LIGHT system.